RDEB

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Abeona Therapeutics
Abeona TherapeuticsCLEVELAND, OH
1 program
EB-101N/A1 trial
Active Trials
NCT05708677Enrolling By InvitationEst. Aug 2036

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Abeona TherapeuticsEB-101

Clinical Trials (1)

A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB

Start: Feb 2021Est. completion: Aug 2036
N/AEnrolling By Invitation

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space